Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2), also known as IRSp53, is a multifunctional adaptor protein that acts as a central integrator of membrane curvature, actin cytoskeleton remodeling, and Rho-family GTPase signaling[1][4]. It contains a conserved N-terminal IMD (IRSp53/MIM homology) domain that binds and deforms cellular membranes, facilitating the formation of filopodia and lamellipodia in motile cells[1]. The C-terminal SH3 domain enables recruitment of actin regulatory proteins (such as Mena, Eps8, WASF family, and Arp2/3 complex), allowing BAIAP2 to spatially and temporally regulate actin assembly in coordination with Rac1 and Cdc42 pathways[1][4]. BAIAP2 is pivotal for cell migration, invasion, and neuronal morphogenesis, with critical roles in growth cone guidance, synaptic structure, and developmental patterning. Disease associations include its fusion with FGFR3 in some bladder cancers generating oncogenic signals, and its interaction with the DRPLA gene implicated in autosomal dominant neurodegenerative disorders[1][4]. It is also exploited by certain pathogens to modulate host cytoskeletal architecture[1]. The dynamic coordination of membrane deformation and actin remodeling by BAIAP2/IRSp53 underscores its importance in both physiological and pathological cellular processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2).